A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5
The potential benefits of drug repurposing have gained attention as an alternative to developing de novo drugs. The potential of using central nervous system (CNS) drugs as anticancer drugs has been explored in several types of human cancers, such as breast and colon cancer, among others. Here, we e...
Main Authors: | Maria João Gouveia, Eduarda Ribeiro, Nuno Vale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/2/212 |
Similar Items
-
Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01) -
In Vitro Drug Repurposing: Focus on Vasodilators
by: Eduarda Ribeiro, et al.
Published: (2023-02-01) -
Repurposing of the Drug Tezosentan for Cancer Therapy
by: Eduarda Ribeiro, et al.
Published: (2023-06-01) -
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
by: Diana Duarte, et al.
Published: (2020-12-01) -
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)